Index of artpub/2023/289373/

Martin, Thomas
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma : updated results from IKEMA, a randomized Phase 3 study
2023
https://ddd.uab.cat/record/289373